The Draft Project Plan on WP5-SA6 ‘Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C’ was open to public consultation between June 23, 2015 and July 7, 2015.
We are pleased to announce that the eight adapted methodological guidelines for Relative Effectiveness Assessment (REA) developed in JA1 and revised by WP7 - Subgroup 3 in JA2, are ready for public consultation..
We are pleased to announce that as of today the HTA Core Model for rapid Relative Effectiveness Assessments, by Work Package 5, has entered the public consultation phase.